Manalapan, NJ, United States of America

Michael Dunn


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Dunn - Innovator in Meniscal Tissue Regeneration

Introduction

Michael Dunn is an accomplished inventor based in Manalapan, NJ (US). He has made significant contributions to the field of biomedical engineering, particularly in the area of tissue regeneration. His innovative work focuses on developing methods that enhance the healing process of meniscal tissue.

Latest Patents

Michael Dunn holds a patent for a "Polymer filament reinforced scaffold for partial meniscus regeneration." This patent describes a method for fabricating a resorbable scaffold that aids in the regeneration of meniscal tissue. The process involves using 3D printing technology to create a polymer filament network based on a digital model. The scaffold features a unique design, incorporating layers of circumferentially-oriented and radially-oriented filaments, which mimic the natural geometry of meniscal tissue.

Career Highlights

Michael Dunn is affiliated with Rutgers, the State University of New Jersey, where he continues to advance his research in tissue engineering. His work has garnered attention for its potential applications in orthopedic medicine and regenerative therapies. With 1 patent to his name, he is recognized for his innovative approach to solving complex medical challenges.

Collaborations

Michael has collaborated with notable colleagues, including Salim A Ghodbane and Charles Gatt, Jr. These partnerships have further enriched his research and contributed to the development of groundbreaking solutions in the field.

Conclusion

Michael Dunn's contributions to meniscal tissue regeneration exemplify the impact of innovative thinking in biomedical engineering. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in orthopedic care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…